Viw Magazine

Men's Weekly

.

  • Written by Rob Grenfell, Director of Health and Biosecurity, CSIRO
Shutterstock

The World Health Organisation said this week it may be 18 months before a vaccine against the coronavirus is publicly available.

Let’s explore why, even with global efforts, it might take this long.

China shared publicly the full RNA sequence of the virus – now known as SARS-CoV-2 rather than COVID-19, which refers to the disease itself – in the first half of January.

This kickstarted efforts to develop vaccines around the world, including at the University of Queensland and institutions in the US and Europe.

By late January, the virus was successfully grown outside China for the first time, by Melbourne’s Doherty Institute, a critically important step. For the first time, researchers in other countries had access to a live sample of the virus.

Using this sample, researchers at CSIRO’s high-containment facility (the Australian Animal Health Laboratory) in Geelong, could begin to understand the characteristics of the virus, another crucial step in the global effort towards developing a vaccine.

Vaccines have historically taken two to five years to develop. But with a global effort, and learning from past efforts to develop coronavirus vaccines, researchers could potentially develop a vaccine in a much shorter time.


Read more: When will there be a coronavirus vaccine? 5 questions answered


Here’s why we need to work together

No single institution has the capacity or facilities to develop a vaccine by itself. There are also more stages to the process than many people appreciate.

First, we must understand the virus’s characteristics and behaviour in the host (humans). To do this, we must first develop an animal model.

Next, we must demonstrate that potential vaccines are safe and can trigger the right parts of the body’s immunity, without causing damage. Then we can begin pre-clinical animal testing of potential vaccines, using the animal model.

First, we must understand the characteristics and behaviour of the virus in its host. Shutterstock

Vaccines that successfully pass pre-clinical testing can then be used by other institutions with the capacity to run human trials.

Where these will be conducted, and by whom, has yet to be decided. Generally, it is ideal to test such vaccines in the setting of the current outbreak.


Read more: Explainer: how do drugs get from the point of discovery to the pharmacy shelf?


Finally, if a vaccine is found to be safe and effective, it will need to pass the necessary regulatory approvals. And a cost-effective way of making the vaccine will also need to be in place before the final vaccine is ready for delivery.

Each of these steps in the vaccine development pipeline faces potential challenges.

Here are some of the challenges we face

The international Coalition for Epidemic Preparedness Innovations has engaged our team in those first two steps: determining the characteristics of the current virus, then pre-clinical testing of potential vaccines.

While Melbourne’s Doherty Institute and others have been instrumental in isolating the novel coronavirus, the next step for us is growing large amounts of it so our scientists have enough to work with. This involves culturing the virus in the lab (encouraging it to grow) under especially secure and sterile conditions.

The next challenge we face is developing and validating the right biological model for the virus. This will be an animal model that gives us clues to how the coronavirus might behave in humans.

Our previous work with SARS (severe acute respiratory syndrome) has given us a good foundation to build on.


Read more: Is the coronavirus outbreak as bad as SARS or the 2009 influenza pandemic? A biologist explains the clues


SARS is another member of the coronavirus family that spread during 2002-03. Our scientists developed a biological model for SARS, using ferrets, in work to identify the original host of the virus: bats.

SARS and the new SARS-CoV-2 share about 80-90% of their genetic code. So our experience with SARS means we are optimistic our existing ferret model can be used as a starting point for work on the novel coronavirus.

We will also explore other biological models to provide more robust data and as a contingency.

What good will a vaccine be if the virus mutates?

There’s also the strong possibility that SARS-CoV-2 will continue to mutate.

Being an animal virus, it has already likely mutated as it adapted – first to another animal, and then jumping from an animal to humans.

Initially this was without transmission among people, but now it has taken the significant step of sustained human-to-human transmission.


Read more: Coronavirus outbreak: a new mapping tool that lets you scroll through timeline


As the virus continues to infect people, it is going through something of a stabilisation, which is part of the mutation process.

This mutation process may even vary in different parts of the world, for various reasons.

This includes population density, which influences the number of people infected and how many opportunities the virus has to mutate. Prior exposure to other coronaviruses may also influence the population’s susceptibility to infection, which may result in variant strains emerging, much like seasonal influenza.


Read more: A clue to stopping coronavirus: Knowing how viruses adapt from animals to humans


Therefore, it’s crucial we continue to work with one of the latest versions of the virus to give a vaccine the greatest chance of being effective.

All this work needs to be done under stringent quality and safety conditions, to ensure it meets global legislative requirements, and to ensure staff and the wider community are safe.

Other challenges ahead

Another challenge is manufacturing proteins from the virus needed to develop potential vaccines. These proteins are specially designed to elicit an immune response when administered, allowing a person’s immune system to protect against future infection.

Fortunately, recent advances in understanding viral proteins, their structure and functions, has allowed this work to progress around the world at considerable speed.

Developing a vaccine is a huge task and not something that can happen overnight. But if things go to plan, it will be much faster than we’ve seen before.


Read more: SARS, MERS ...? Preparing for the next coronavirus pandemic


So many lessons were learned during the SARS outbreak. And the knowledge the global scientific community gained from trying to develop a vaccine against SARS has given us a head-start on developing one for this virus.

Trevor Drew receives funding from: Coalition for Epidemic PReparedness & Innovation, Australian Dept for Agriculture, Australian Dept for Foreign Affairs & Trade, Fisheries Disease Research Council, Food & Agriculture Organisation of the UN, World Organisation for Animal Health. Employee by CSIRO - an agency of the Australian Dept for Industry, Innovation and Skills.

Rob Grenfell does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Authors: Rob Grenfell, Director of Health and Biosecurity, CSIRO

Read more https://theconversation.com/heres-why-the-who-says-a-coronavirus-vaccine-is-18-months-away-131213

Designing the Ideal Healthcare Environment with a Professional Medical Centre Fitout

When it comes to healthcare spaces, functionality, hygiene, and patient comfort take top priority. An intelligently designed medical centr...

Stay Comfortable Year-Round with Ducted Cooling Melbourne

When the temperature starts to rise, having a reliable and efficient cooling system becomes a priority. With unpredictable weather and sud...

Best Practices for Content Ownership and Tagging Across Departments

Image by kaboompics on Freepik The bigger and more complex content ecosystems grow, the more valuable ownership and tagging become. In ent...

Understanding Public Liability Insurance Australia: What You Need to Know

Image by rawpixel.com on Freepik The necessity of public liability insurance in Australia is that it acts as a financial safeguard for busi...

How HID Proximity Cards Improve Workplace Security Without Slowing Down Access

In today’s workplaces, security is non-negotiable, but so is speed. Companies are under pressure to protect their people, property, and ...

Unlock Business Insights Faster with Power BI Tools

In this digital age where data drives the consumer landscape, businesses are shipping huge amounts of data every day. To remain competit...

Why Split System Installation Is a Smart Choice for Home Climate Control

Temperature control is essential for comfort, and when it comes to efficient, versatile cooling and heating, a split system is one of the ...

The Ultimate Guide to Door Replacement: Everything You Need to Know

Image by freepik Sure, swapping out a door is a fairly easy task, but it requires careful consideration of options for materials, designs...

Common Web Development Issues Perth Businesses Face (and How Agencies Fix Them)

Image by freepik Let's be honest, in the bustling heart of Perth's business scene, a website that's not up to scratch is like trying to he...

Life With Clear Aligners: 10 Small Changes That Make a Big Difference

Image by tonodiaz on Freepik Clear aligners have transformed orthodontics, offering a nearly invisible way to straighten teeth without the...

Choosing the Right Hair Loss Treatment for Your Needs

Millions of people experience hair loss globally, and it can be a major cause of emotional discomfort and self-consciousness. Hair loss ca...

Cardboard Display Boxes: An Effective Solution for Retail Presentation

In the competitive world of retail, how products are presented can be just as important as the products themselves. Cardboard display boxe...

Why Hiring a Skilled Shopify Web Developer Can Transform Your Online Store

Shopify has become one of the most popular e-commerce platforms due to its ease of use, powerful features, and scalability. However, creat...

Selling a Home Left 1 in 3 Aussies in Tears, Survey Finds

New research on selling property found that more than 1 in 3 people who sold a property in the past two years admitted to crying at some poi...

Brisbane Motor Vehicle Accident Lawyers & Motorbike Accident Claims

Motorbike accidents in Brisbane can lead to severe injuries and complex legal challenges, given the vulnerability of riders on the road. F...

Jesse Martin, OAM Sets Sail Again with Portland Roads - Sailing the Whitsundays

Jesse Martin OAM shot to fame in 1999 as the world’s youngest sailor to circumnavigate the globe – solo, unassisted and non-stop. No...

Why Modern Roller Shutters Are the Perfect Solution for Your Home or Business

Whether you're looking to secure your home or make your business more energy-efficient, modern roller shutters are a smart choice. In this...

Everything You Need to Know About the EWPA Yellow Card

The EWPA Yellow Card is an important certification in the construction and workplace safety sectors. It plays a key role in ensuring worke...

From Residential to NDIS to Commercial: How Mr Window Cleaning Covers Every Window

Not all window cleaning jobs are created equal. A quiet suburban home, a bustling retail store, and a property under an NDIS plan each com...

How Timely Duct Inspections and Repairs Improve HVAC Efficiency

You have cranked up the air conditioning, but your home still feels unevenly cooled or stuffy. Sound familiar? Many homeowners jump straig...